TIDO Staffing Update:
A warm welcome to Nadine Beauger,
Senior Director–new Therapeutic Accelerator
We are pleased to announce that Nadine Beauger, PhD, MBA, is joining TIDO as Senior Director of our newly established Therapeutic Accelerator. Nadine will play an integral role in driving hospital innovations to advance our mission of improving the health and well-being of children around the world. She will oversee critical initiatives such as the Technology Development Fund (TDF), the hospital’s Drug, Device, and Diagnostics Accelerator (D3A), and our strategic alliances with industry partners. Her leadership will also extend to managing other key commercialization efforts that align with our commitment to transforming our cutting-edge research into tangible solutions for pediatric patients.
Previously President and CEO of IRICoR, a Centre of Excellence in Commercialization and Research specializing in drug discovery at IRIC/University of Montreal, Nadine brings over two decades of expertise in the life sciences industry to Boston Children’s Hospital. She also sits as Director on various boards. With her exceptional track record of bridging the translational gap between groundbreaking research and successful commercialization, broad experience in corporate and business strategy, work in technology identification and transfer, project management, and drug discovery, Nadine will undoubtedly propel our Therapeutic Accelerator towards unparalleled success in catalyzing the next generation of pediatric healthcare innovations.
Please join us in extending a warm welcome to her as she embarks on this exciting new chapter with Boston Children’s Hospital.